Skip to main content

Table 2 Plaque progression in different tertiles of MPO levels in patients with type 2 diabetes

From: Serum MPO levels and activities are associated with angiographic coronary atherosclerotic plaque progression in type 2 diabetic patients

Tertiles of MPO levels

n

Follow-up duration, (months)

Plaque progression, n (%)

Changes in MLD, (mm)

Changes in stenosis diameter, (%)

Changes in CCSS

T1

84

12.18 ± 1.44

34 (42.0)

0.17 ± 0.26

 − 4.37 ± 6.82

 − 0.11 ± 0.11

T2

82

12.26 ± 1.26

54 (65.9)

0.34 ± 0.32

 − 13.52 ± 12.97

 − 0.18 ± 0.15

T3

82

12.38 ± 1.05

73 (85.9)

0.74 ± 0.40

 − 25.44 ± 12.14

 − 0.38 ± 0.22

P value

 

0.591

 < 0.001

 < 0.001

 < 0.001

 < 0.001

  1. Values are given as mean ± standard deviation (SD) or number (percentage)
  2. Change of QCA measurement is defined as baseline QCA measurement minus follow-up measurement
  3. Tertiles of MPO levels: T1 ≤ 20.500 ng/mL; 20.500 < T2 ≤ 38.317 ng/ mL; T3 > 38.317 ng/mL
  4. MLD Minimal lumen diameter, CCSS Cumulative coronary stenosis score, QCA Quantitative coronary analyses
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us